CRT reduces ventricular arrhythmias via reverse remodeling or whether resynchronization and shortening ventricular activation time confers a persistent antiarrhythmic effect. 8 The MADIT CRT and a recent meta analysis 8 -10 provide ev idence that CRT mediated left ventricular im provement is antiarrhythmic. In the absence of reverse remodeling, CRT with left ventricular epi cardial stimulation may be proarrhythmic. 11 Re cent data suggest that CRT may be antiarrhyth mic in primary prevention recipients and proar rhythmic in secondary prevention recipients. 8 The authors of the study stated that "in the long term follow up, previous myocardial infarction was also predictor of ICD interven tions." 1 It is tempting to speculate that ongo ing ischemia could explain this finding. Never theless, this differs from a 2010 study that re ported no significant difference in the incidence of appropriate ICD shocks in patients with isch emic versus nonischemic cardiomyopathy at the 33 month follow up. 12 Winkler et al 1 correctly noted that understand ing the relationship between severe mitral regur gitation and appropriate device therapy is chal lenging. The major causes of severe mitral regur gitation include primary valvular diseases (most commonly mitral valve prolapse) 13 and second ary (functional) valvular dysfunction due to coro nary artery disease or cardiomyopathy. 14 The pre cise relationship between mitral valve prolapse and SCD remains uncertain and the increased SCD risk may be related to the valvular regurgi tation rather than the abnormality in the valve's structural apparatus. 15 While secondary mitral regurgitation is associated with poor prognosis beyond the degree of left ventricular dysfunc tion, survival rates vary inversely with mitral re gurgitation severity, 16 and death may be related to hemodynamic failure or a sudden arrhythmic In this issue of Polish Archives of Internal Medicine (Pol Arch Intern Med), Winkler et al 1 identify pre dictors of mortality and appropriate interventions in implantable cardioverter defibrillator (ICD) re cipients. This is important because the extent to which individual patients benefit from an ICD varies considerably. 2 The study group included primary and second ary prevention device recipients. It is unsurpris ing that secondary prevention patients received more appropriate ICD interventions for ventric ular arrhythmias. Although some programming features are noted, there is no breakdown of ther apies into antitachycardia pacing (ATP) and shock delivery. Taken as a group, patients who received shocks had higher ventricular arrhythmia bur den and poorer survival than patients treated only with ATP. 3 In the SCDHeFT (Sudden Car diac Death in Heart Failure Trial) post hoc anal ysis, shocks (appropriate or not) were associat ed with poorer survival in patients with ICDs. 4,5 This has spurred interest in shock reduction with out increasing syncope or sudden cardiac death (SCD) rates. Shocks can be reduced by appropriate programming, 4,6 allowing longer detection times and longer arrhythmia duration before shock de livery. The MADIT RIT (Multicenter Automatic Defibrillator Implantation Trial -Reduce Inap propriate Therapy) demonstrated that such pro gramming can be associated with improved pa tient survival. 4,7 Strategic programming of ICD tachycardia detection and therapies is therefore recommended. 4,6
Although Winkler et al 1 found that cardiac re synchronization therapy (CRT) reduced the risk of appropriate ICD therapy in primary prevention, the influence of CRT on ventricular arrhythmias is uncertain. While some studies suggest a proar rhythmic effect, others suggest an antiarrhythmic effect. In particular, it remains unclear whether event. 17 Mitral valve repair or replacement may improve symptoms of secondary mitral regurgi tation, but there is no evidence that it improves survival. 16 CRT recipients with severe mitral re gurgitation have higher mortality rates, and per sistent moderate to severe mitral regurgitation post CRT has been associated with poorer clini cal outcomes (survival rates are higher with mi tral regurgitation improvement), 16,18 a higher in cidence of arrhythmic events, and less reverse remodeling. 19,20
It is not surprising that the authors found that "total mortality is strongly affected by comorbidi ties and natural course of heart failure." 1 ICD ther apy is hardly a panacea. Reeder et al 2 pointed out that weighing the inconvenience and risks of liv ing with an ICD against an expected survival ad vantage is often far from straightforward. Many ICD recipients are older patients with multiple comorbidities and individual choices between ex tended survival, ICD shocks, and quality of life may not be clear cut. 2 They performed a second ary analysis of the ICD recipients from the SCD HeFT and applied an illness death regression model to concurrently model both ICD shocks and death to help predict each patient's probability of having received ICD shocks, dying, or both at any given point in time. If validated, their tool may be useful for individualized counseling regard ing likely outcomes after device implantation. 2 While laudable, the current study reminds us that our ability to predict individual outcomes of ICD therapy remains incomplete. Although there is more work to be done, motivation to provide optimal patient care will continue to propel us in the right direction.
